ProQR Therapeutics (PRQR)
(Delayed Data from NSDQ)
$2.10 USD
-0.09 (-4.11%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $2.11 +0.01 (0.48%) 7:58 PM ET
4-Sell of 5 4
F Value F Growth D Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, ProQR Therapeutics N.V. has a market cap of $230.41M, which represents its share price of $2.19 multiplied by its outstanding shares number of 105.21M. As a small-cap company, PRQR's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
PRQR 2.10 -0.09(-4.11%)
Will PRQR be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for PRQR based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PRQR
Intellia Therapeutics, Inc. (NTLA) Reports Q2 Loss, Beats Revenue Estimates
Techne (TECH) Q3 Earnings and Revenues Beat Estimates
PRQR: What are Zacks experts saying now?
Zacks Private Portfolio Services
Strength Seen in BioNTech (BNTX): Can Its 6.0% Jump Turn into More Strength?
ProQR (PRQR) Reports Q4 Loss, Lags Revenue Estimates
Krystal Biotech, Inc. (KRYS) Beats Q3 Earnings and Revenue Estimates
Other News for PRQR
Is PRQR positioned for a breakdown? Non-ADX 1,2,3,4 Bearish shows up after sinking 4.11%
Crossed Above 200 Day Moving Average appears for PRQR after 6.31% move
PRQR rises 3.52% on September 18, leaving the technical picture intact
MACD Bearish Centerline Cross appears for PRQR after 0.25% move
Fell Below 200 Day Moving Average appears for PRQR after 9.36% move